{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:43:39Z","timestamp":1789879419303,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Grifols"},{"name":"Grifols"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rmed.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:22:43Z","timestamp":1507832563000},"page":"132-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Prevalence of comorbidities in COPD patients by disease severity in a German population"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-3014","authenticated-orcid":false,"given":"Timm","family":"Greulich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-0305","authenticated-orcid":false,"given":"Benjamin J.D.","family":"Weist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Rembert","family":"Koczulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Janciauskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Klemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus F.","family":"Vogelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rmed.2017.10.007_bib1","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary","volume":"49","author":"Vogelmeier","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2017.10.007_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15412550903140865","article-title":"Identifying individuals with physician diagnosed COPD in health administrative databases","volume":"6","author":"Gershon","year":"2009","journal-title":"Copd"},{"issue":"6","key":"10.1016\/j.rmed.2017.10.007_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/15412555.2011.636555","article-title":"Insights into COPD comorbidities from the OLIN study and other large databases","volume":"8","author":"Mapel","year":"2011","journal-title":"COPD"},{"issue":"9","key":"10.1016\/j.rmed.2017.10.007_bib4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.rmed.2013.05.001","article-title":"Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort","volume":"107","author":"Miller","year":"2013","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2017.10.007_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","article-title":"Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease","volume":"187","author":"Vanfleteren","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2017.10.007_bib6","doi-asserted-by":"crossref","first-page":"e004495","DOI":"10.1136\/bmjopen-2013-004495","article-title":"The COgnitive-Pulmonary Disease (COgnitive-PD) study: protocol of a longitudinal observational comparative study on neuropsychological functioning of patients with COPD","volume":"4","author":"Cleutjens","year":"2014","journal-title":"BMJ open"},{"key":"10.1016\/j.rmed.2017.10.007_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6963-11-43","article-title":"Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data","volume":"11","author":"Mapel","year":"2011","journal-title":"BMC health Serv. Res."},{"issue":"11","key":"10.1016\/j.rmed.2017.10.007_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thx.2009.128082","article-title":"Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care","volume":"65","author":"Feary","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09031936.00061414","article-title":"Quantifying comorbidity in individuals with COPD: a population study","volume":"45","author":"Gershon","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"50","key":"10.1016\/j.rmed.2017.10.007_bib10","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1055\/s-0028-1105858","article-title":"The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study","volume":"133","author":"Geldmacher","year":"2008","journal-title":"Dtsch. Med. Wochenschr"},{"key":"10.1016\/j.rmed.2017.10.007_bib11","author":"Office GFS"},{"issue":"12","key":"10.1016\/j.rmed.2017.10.007_bib12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hec.1005","article-title":"Risk selection in the German public health insurance system","volume":"14","author":"Nuscheler","year":"2005","journal-title":"Health Econ."},{"issue":"3","key":"10.1016\/j.rmed.2017.10.007_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.healthpol.2012.12.001","article-title":"The new risk adjustment formula in Germany: implementation and first experiences","volume":"109","author":"Buchner","year":"2013","journal-title":"Health Policy"},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/pds.3895","article-title":"Characteristics and external validity of the German health risk institute (HRI) database","volume":"25","author":"Andersohn","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"10.1016\/j.rmed.2017.10.007_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1183\/13993003.00954-2015","article-title":"Bronchiectasis in Germany: a population-based estimation of disease prevalence","volume":"46","author":"Ringshausen","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2017.10.007_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3201\/eid2206.151642","article-title":"Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009-2014","volume":"22","author":"Ringshausen","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00154-2016","article-title":"The prevalence of diagnosed alpha-1-antitrypsin deficiency and its comorbidities: results from a large population based database","volume":"49","author":"Greulich","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2017.10.007_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thoraxjnl-2012-201945","article-title":"Association between beta-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension","volume":"67","author":"Stefan","year":"2012","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2017.10.007_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amjcard.2012.10.041","article-title":"Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)","volume":"111","author":"Mentz","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2017.10.007_bib20","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2017.10.007_bib21","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/COPD.S111724","article-title":"Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease","volume":"11","author":"Camiciottoli","year":"2016","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00154-2016","article-title":"The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database","volume":"49","author":"Greulich","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2017.10.007_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1513\/pats.201108-050MS","article-title":"Systemic inflammation and comorbidities in chronic obstructive pulmonary disease","volume":"9","author":"Agusti","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"10","key":"10.1016\/j.rmed.2017.10.007_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thx.2009.130260","article-title":"Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence","volume":"65","author":"Sinden","year":"2010","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2017.10.007_bib25","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2017.10.007_bib26","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.rmed.2017.10.007_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10030","key":"10.1016\/j.rmed.2017.10.007_bib28","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.rmed.2017.10.007_bib29","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.rmed.2017.10.007_bib30","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S2213-2600(13)70199-1","article-title":"Integrating real-life studies in the global therapeutic research framework","volume":"1","author":"Roche","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2213-2600(12)70060-7","article-title":"Chronic obstructive pulmonary disease and comorbidities","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.rmed.2017.10.007_bib32","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.rmed.2013.05.001","article-title":"Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort","volume":"107","author":"Miller","year":"2013","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.rmed.2017.10.007_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thx.2009.128082","article-title":"Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care","volume":"65","author":"Feary","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09031936.00061414","article-title":"Quantifying comorbidity in individuals with COPD: a population study","volume":"45","author":"Gershon","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2017.10.007_bib35","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2017.10.007_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2049-6958-10-4","article-title":"INDACO project: COPD and link between comorbidities, lung function and inhalation therapy","volume":"10","author":"Fumagalli","year":"2015","journal-title":"Multidiscip. Respir. Med."},{"key":"10.1016\/j.rmed.2017.10.007_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1472-6963-11-37","article-title":"The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease","volume":"11","author":"Cooke","year":"2011","journal-title":"BMC health Serv. Res."},{"issue":"5 Pt 2","key":"10.1016\/j.rmed.2017.10.007_bib38","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","article-title":"Measuring diagnoses: ICD code accuracy","volume":"40","author":"O'Malley","year":"2005","journal-title":"Health Serv. Res."},{"issue":"11","key":"10.1016\/j.rmed.2017.10.007_bib39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117303463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117303463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:40:45Z","timestamp":1760614845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117303463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"alternative-id":["S0954611117303463"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.10.007","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of comorbidities in COPD patients by disease severity in a German population","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}